Paclitaxel-dependent cell lines reveal a novel drug activity.
We previously described the isolation of Tax 18 and Tax 11-6, two paclitaxel-dependent cell lines that assemble low amounts of microtubule polymer and require the drug for cell division. In the present studies, fluorescence time-lapse microscopy was used to measure microtubule dynamic instability behavior in these cells. The mutations were found to cause small decreases in microtubule growth and shortening, but the changes seemed unable to explain the defects in microtubule polymer levels or cell division. Moreover, paclitaxel further suppressed microtubule dynamics at low drug concentrations that were insufficient to rescue the mutant phenotype. Wild-type (WT) cells treated with similar low drug concentrations also had highly suppressed microtubules, yet experienced no problems with cell division. Thus, the effects of paclitaxel on microtubule dynamics seemed to be unrelated to cell division in both WT and mutant cell lines. The higher drug concentrations needed to rescue the mutant phenotype instead inhibited the formation of unstable microtubule fragments that appeared at high frequency in the drug-dependent, but not WT, cell lines. Live cell imaging revealed that the fragments were generated by microtubule detachment from centrosomes, a process that was reversed by paclitaxel. We conclude that paclitaxel rescues mutant cell division by inhibiting the detachment of microtubule minus ends from centrosomes rather than by altering plus-end microtubule dynamics.
Department of Integrative Biology and Pharmacology, The University of Texas Medical School, 6431 Fannin St., Houston, TX 77030, USA.
Anutosh
A
Ganguly
Hailing
H
Yang
Fernando
F
Cabral
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D016466:CHO Cells; D002460:Cell Line / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D049109:Cell Proliferation / Q000187:drug effects*; D018385:Centrosome / Q000378:metabolism; D006224:Cricetinae; D003412:Cricetulus; D004353:Drug Evaluation, Preclinical; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism; D030781:Organisms, Genetically Modified; D017239:Paclitaxel / Q000494:pharmacology*; D050257:Tubulin Modulators / Q000494:pharmacology*
D000972:Antineoplastic Agents, Phytogenic; D050257:Tubulin Modulators; D017239:Paclitaxel